Integra Lifesciences Holdings vs Integer Holdings
Integra Lifesciences Holdings and Integer Holdings are similar in size: $1.64bn and $1.85bn of revenue in their latest fiscal years. Integer Holdings grew faster (8.0% against 1.5%). Integer Holdings kept more of each dollar of sales as profit: a net margin of 5.5% against -31.6%. Integer Holdings carries less debt relative to equity (69.1% against 165.8%).
| Latest fiscal year | Integra Lifesciences HoldingsIART, 2025 | Integer HoldingsITGR, 2025 |
|---|---|---|
| Revenue | $1.64bn | $1.85bn |
| Revenue growth | 1.5% | 8.0% |
| Net income | −$516m | $103m |
| Operating margin | -30.2% | 11.9% |
| Net margin | -31.6% | 5.5% |
| Return on equity | -39.9% | 6.1% |
| Free cash flow | −$31.1m | $105m |
| Cash | $235m | $17.2m |
| Total debt | $1.73bn | $1.21bn |
| Debt to equity | 165.8% | 69.1% |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | $221,000 | $50.0m |
| Employees | — | 11,000 |
| Market value | $1.07bn | $4.31bn |
| Price vs our value range | — | Above our value range |
| Moat score | 51 (Moderate) | 60 (Moderate) |
| Insider trades, 12 months | 1 buys, 0 sales | 3 buys, 5 sales |